{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:46:34Z","timestamp":1762505194020},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T00:00:00Z","timestamp":1164672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T00:00:00Z","timestamp":1164672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s00192-006-0239-y","type":"journal-article","created":{"date-parts":[[2006,11,27]],"date-time":"2006-11-27T19:14:26Z","timestamp":1164654866000},"page":"737-741","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms"],"prefix":"10.1007","volume":"18","author":[{"given":"Linda","family":"Brubaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary P.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,28]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/nau.10053","volume":"21","author":"P van Kerrebroeck","year":"2002","unstructured":"van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179\u2013183","journal-title":"Neurourol Urodyn"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/00365590310020033","volume":"38","author":"R Lundgren","year":"2004","unstructured":"Lundgren R (2004) Nocturia: a new perspective on an old symptom. Scand J Urol Nephrol 38:112\u2013116","journal-title":"Scand J Urol Nephrol"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/nau.20189","volume":"24","author":"R Svatek","year":"2005","unstructured":"Svatek R, Roche V, Thornberg J, Zimmern P (2005) Normative values for the American Urological Association Symptom Index (AUA-7) and short form Urogenital Distress Inventory (UDI-6) in patients 65 and older presenting for non-urological care. Neurourol Urodyn 24:606\u2013610","journal-title":"Neurourol Urodyn"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1464-410X.2005.05407.x","volume":"95","author":"R Asplund","year":"2005","unstructured":"Asplund R, Marnetoft SU, Selander J, Akerstrom B (2005) Nocturia in relation to somatic health, mental health and pain in adult men and women. BJU Int 95:816\u2013819","journal-title":"BJU Int"},{"key":"239_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1464-410X.2003.04062.x","volume":"91","author":"G Kobelt","year":"2003","unstructured":"Kobelt G, Borgstrom F, Mattiasson A (2003) Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int 91:190\u2013195","journal-title":"BJU Int"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1464-410X.2003.04527.x","volume":"92","author":"KS Coyne","year":"2003","unstructured":"Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E (2003) The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 92:948\u2013954","journal-title":"BJU Int"},{"key":"239_CR7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1532-5415.1992.tb03645.x","volume":"40","author":"RB Stewart","year":"1992","unstructured":"Stewart RB, Moore MT, May FE, Marks RG, Hale WE (1992) Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 40:1217\u20131220","journal-title":"J Am Geriatr Soc"},{"key":"239_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1464-410x.1999.00157.x","volume":"84","author":"R Asplund","year":"1999","unstructured":"Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297\u2013301","journal-title":"BJU Int"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"239_CR10","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/01.ju.0000140729.07840.16","volume":"172","author":"L Cardozo","year":"2004","unstructured":"Cardozo L, Lisec M, Millard R et al (2004) Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 172:1919\u20131924","journal-title":"J Urol"},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","volume":"93","author":"CR Chapple","year":"2004","unstructured":"Chapple CR, Rechberger T, Al-Shukri S et al (2004) Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303\u2013310","journal-title":"BJU Int"},{"key":"239_CR12","unstructured":"Gittelman M, Chu F, Klimberg I, Fincher R, Smith N, Tempel D, Ridge S (2003) Two randomized, double-blind, placebo-controlled, parallel-group, fixed-dose, multicenter studies assess the efficacy and safety of daily oral administration of 10\u00a0mg YM905 (solifenacin succinate; Vesicare\u00ae) versus placebo in male and female subjects with overactive bladder. Poster presented at the American Urological Association Annual Meeting; April 26\u2013May 1, 2003; Chicago, IL (on behalf of the YM905 Study Group)"},{"key":"239_CR13","first-page":"351","volume":"37","author":"PH van Elteren","year":"1960","unstructured":"van Elteren PH (1960) On the combination of independent two-sample tests of Wilcoxon. Bull Inst Int Stat 37:351\u2013361","journal-title":"Bull Inst Int Stat"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0022-5347(05)67961-X","volume":"163","author":"JP Weiss","year":"2000","unstructured":"Weiss JP, Blaivas JG (2000) Nocturia. J Urol 163:5\u201312","journal-title":"J Urol"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.ajog.2004.11.033","volume":"192","author":"NL Drake","year":"2005","unstructured":"Drake NL, Flynn MK, Romero AA, Weidner AC, Amundsen CL (2005) Nocturnal polyuria in women with overactive bladder symptoms and nocturia. Am J Obstet Gynecol 192:1682\u20131686","journal-title":"Am J Obstet Gynecol"},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<467::AID-NAU2>3.0.CO;2-B","volume":"17","author":"JP Weiss","year":"1998","unstructured":"Weiss JP, Blaivas JG, Stember DS, Brooks MM (1998) Nocturia in adults: etiology and classification. Neurourol Urodyn 17:467\u2013472","journal-title":"Neurourol Urodyn"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1532-5415.2005.53260.x","volume":"53","author":"TM Johnson II","year":"2005","unstructured":"Johnson TM II, Burgio KL, Redden DT, Wright KC, Goode PS (2005) Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 53:846\u2013850","journal-title":"J Am Geriatr Soc"},{"key":"239_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.1464-410X.2003.04363.x","volume":"92","author":"KJ Kreder Jr","year":"2003","unstructured":"Kreder KJ Jr, Brubaker L, Mainprize T (2003) Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int 92:418\u2013421","journal-title":"BJU Int"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1464-410X.2005.05454.x","volume":"95","author":"C Chapple","year":"2005","unstructured":"Chapple C, Steers W, Norton P et al (2005) A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M selective receptor antagonist, in the treatment of overactive bladder. BJU Int 95:993\u20131001","journal-title":"BJU Int"},{"issue":"3","key":"239_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00192-005-1340-3","volume":"17","author":"S Hill","year":"2005","unstructured":"Hill S, Khullar V, Wyndaele JJ, Lheritier K (2005) Dose response with darifenacin, a novel once-daily M(3) selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study. Int Urogynecol J Pelvic Floor Dysfunct 17(3):239\u2013247","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-006-0239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-006-0239-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-006-0239-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-006-0239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T02:04:44Z","timestamp":1652580284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-006-0239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,28]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s00192-006-0239-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,28]]},"assertion":[{"value":"21 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}